期刊文献+

苯并硫氮杂类化合物的研究进展 被引量:1

The development of benzothiazepine derivatives
暂未订购
导出
摘要 在寻找先导化合物的过程中,苯并硫氮杂类化合物占有非常重要的位置。按照结构类型,苯并硫氮杂类主要包括1,3-、1,4-、4,1-和1,5-苯并硫氮杂四大类。它们可以作用于许多不同家族的靶点,显示出了广泛的生物学活性。在苯并硫氮杂类化合物中,1,5-苯并硫氮杂类化合物的生物学活性最为广泛,可以作为钙离子通道拮抗剂、某些蛋白激酶的抑制剂、一些G蛋白偶联受体的拮抗剂以及缓激肽激动剂等。作者对苯并硫氮杂类化合物的研究进展进行了综述。 Benzothiazepine derivatives are of great importance in the discovery of lead compounds. Benzothiazepine can be devided into four types according to structure, i. e. 1, 3-, 1, 4-, 4, 1- and 1, 5-benzothiazepine. They can act on different families of targets and show wide range of biological activities. Among all the benzothiazepine derivatives, 1,5-benzothiazepine derivatives was the most important because of its wide biological activities. They can be used as calcium channel blockers, protease inhibitors, antagonists of several G-protein-coupled receptors and bradykinin agonists. In this article, the biological activities and synthetic methods are reviewed.
作者 赵海燕 刘刚
出处 《中国药物化学杂志》 CAS CSCD 2007年第2期122-128,共7页 Chinese Journal of Medicinal Chemistry
关键词 苯并硫氮杂革 优势结构 钙通道拮抗剂 蛋白激酶抑制剂 缓激肽激动剂 benzothiazepine privileged structure calcium channel blockers protease in hibitors bradykinin agonists
  • 相关文献

参考文献49

  • 1CAMPIANI G,NACCI V,BECHELLI S,et al.New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure[J].J Med Chem,1998,41(20):3763-3772.
  • 2CAMPIANI G,BUTINI S,GEMMA S,et al.Pyrrolo[1,3]benzothiazepine-based atypical antipsychotic agents:Synthesis,structure-activity relationship,molecular modeling,and biological studies[J].J Med Chem,2002,45(2):344-359.
  • 3CAMPIANI G,BUTINI S,FATTORUSSO C,et al.Pyrrolo[1,3] benzothiazepine-based serotonin and dopamine receptor antagonists:molecular modeling,further structure-activity relationship studies,and identification of novel atypical antipsychotic agents[J].J Med Chem,2004,47(1):143-157.
  • 4LEHNART S E,TERRENOIRE C,REIKEN S,et al.Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias[J].PNAS,2006,103(20):7906-7910.
  • 5ISY O,BURNETT J C,Jr.New cardioprotective agent K201 is natriuretic and glomerular filtration rate enhancing[J].Circulation,2006,113(2):246-251.
  • 6CHEX F,NAKAJIMAA Y,SUMIZAWA T,et al.Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative,JTV-519[J].Cancer Lett,2002,187 (1):111-119.
  • 7GRUNEWALD G L,DAHANULKAR V H,CHING P,et al.Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylaminetype inhibitors of phenylethanolamine N-methyltransferase[J].J Med Chem,1996,39 (18):3539 -3546.
  • 8AXELROD J.Purification and properties of phenylethanolamine-N-methyl transferase[J].J Biol Chem,1962,237:1657-1660.
  • 9PERRY B D,STOLK J M,VANTINI G,et al.Strain difference in rat brain epinephrine synthesis regulation of a-adrenergic receptor number by epinephrine[J].Science,1983,221(4617):1297-1299.
  • 10NEAMATI N,TURPIN J A,WINSLOW H E,et al.Thiazolothiazepine inhibitors of HIV-1 integrase[J].J Med Chem,1999,42(17):3334-3341.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部